Dominari Holdings Inc.

2.35 USD
+0.25 (+12.17%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Dominari Holdings Inc. stock is down -14.86% since 30 days ago. The next earnings date is Aug 7, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 20% of the previous 4 May’s closed higher than April.

About Dominari Holdings Inc.

AIkido Pharma Inc. focuses on developing small-molecule anti-cancer therapeutics. Its pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. The company is also developing an antiviral platform that inhibits replication of viruses.